REQUEST FOR THE PROPOSAL No. 38/2021-ARG – Phase I, First-in-Human type, clinical trial
The order is carried out as a part of the project titled:
– ARG: „PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-415/17)
co-financed by the European Union Funds and carried out on the basis of the competitiveness principle
We hereby look for Contractor ready to perform: Organization and comprehensive execution of the phase I, First-in-Human type, clinical trial for a OATD-02 compound.
On September 28, 2021, the Ordering Party updated the Request, Appendices 1 and 6. The changes are marked in red and appropriately crossed out. In addition, the Ordering Party provides answers to questions that arose by the set deadline. Answers to the questions provided by the Ordering Party constitute an integral part of the documentation concerning the tender procedure. The deadline for submitting offers has been extended to October 15, 2021, at 08:00 am (CET).